Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

QHSLab Inc (QB) USAQ

QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures. The company focuses on value-based healthcare, informatics, and algorithmic personalized medicine, including digital therapeutics, behavior based remote patient monitoring, and chronic care and preventive medicine. Its digital healthcare and clinical decision support and point of care solutions also support non face to face remote patient and therapeutic monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based medical office and mobile patient education solution that provides physicians with dashboard to streamline patient information and business operations; and AllergiEnd, a diagnostic and allergen immunotherapy system for the busy non-allergist in a primary care setting. Its products are designed to promote p...


OTCQB:USAQ - Post by User

User Avatar Image
(18)
•••
  • lelianicruzX
Post by lelianicruzon Jul 16, 2024 11:28am
72 Views
Post# 36134750

Revolutionizing Primary Care: QHSLab's AI-Powered Healthcare

Revolutionizing Primary Care: QHSLab's AI-Powered Healthcare

QHSLab, Inc. (OTC: $USAQ) is at the forefront of digital healthcare innovation, leveraging advanced artificial intelligence algorithms to enhance the capabilities of primary care physicians. By providing cutting-edge solutions, QHSLab enables doctors to effectively screen and monitor their patients' health, ensuring timely and accurate assessments. The company's digital healthcare tools not only streamline the patient evaluation process but also facilitate real-time data transfer, allowing for continuous remote monitoring of vital signs and the impact of newly prescribed treatments.With a market cap of $2,426,183, QHSLab demonstrates significant market potential. The company's stock has shown a 52-week range of $0.0155 to $0.35, reflecting its dynamic market presence and the growing demand for innovative medical devices and diagnostic tests in the healthcare sector.

<< Previous
Bullboard Posts
Next >>